Empyrean Capital Partners, LP - LUX HEALTH TECH ACQUISITION ownership

LUX HEALTH TECH ACQUISITION's ticker is LUXA and the CUSIP is 55068A100. A total of 47 filers reported holding LUX HEALTH TECH ACQUISITION in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.9%.

Quarter-by-quarter ownership
Empyrean Capital Partners, LP ownership history of LUX HEALTH TECH ACQUISITION
ValueSharesWeighting
Q3 2022$30,051,000
+1.3%
3,000,6490.0%0.93%
-1.1%
Q2 2022$29,676,000
+0.3%
3,000,6490.0%0.94%
+45.0%
Q1 2022$29,586,000
+0.6%
3,000,6490.0%0.65%
-16.6%
Q4 2021$29,406,000
+49.8%
3,000,649
+50.0%
0.78%
+79.1%
Q3 2021$19,626,000
-0.8%
2,000,6490.0%0.44%
-3.5%
Q2 2021$19,786,000
+7.0%
2,000,649
+11.1%
0.45%
-14.7%
Q1 2021$18,493,0001,800,6490.53%
Other shareholders
LUX HEALTH TECH ACQUISITION shareholders Q1 2021
NameSharesValueWeighting ↓
Wolfswood Holdings, LLC 2,000,000$19,720,00081.59%
MYDA Advisors LLC 970,000$9,564,0003.78%
RP Investment Advisors LP 1,309,486$12,912,0001.81%
Tuttle Capital Management, LLC 41,697$411,0001.02%
Silver Rock Financial LP 369,442$3,643,0000.69%
Empyrean Capital Partners, LP 3,000,649$29,586,0000.65%
BBR PARTNERS, LLC 639,999$6,310,0000.60%
Governors Lane LP 725,000$7,149,0000.52%
Spartan Fund Management Inc. 226,753$2,795,0000.46%
Senator Investment Group LP 1,473,600$14,530,0000.45%
View complete list of LUX HEALTH TECH ACQUISITION shareholders